Aurora (TSX:ACB) Stock Could See 100% Growth in 2020 If These 3 Things Happen

Aurora stock had a particularly tough go of things in 2019. The company lost close to 63% of its total market stock value in 2019. But if 3 things happen in 2020, the stock could double.

| More on:
Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

There’s no sugarcoating it: 2019 was a rough year for marijuana stocks.

Aurora (TSX:ACB)(NYSE:ACB) stock had a particularly tough go of things. The company lost close to 63% of its total market stock value in 2019, making it one of the worst performers in the marijuana marketplace.

The company has pressed the pause button on some of its more ambitious projects — including two production facilities in Canada — in the wake of an uncertain financial situation.

Yes, Aurora has found a way to cover more than $230 million of convertible debt due on March 2020. But cash flow issues, with a burn rate of nearly $210 million, has investors and industry insiders a little bit concerned about how Aurora turns things around and becomes profitable.

That said, not everything about this company is doom and gloom.

Aurora could bounce back in a big way —  100% growth or more in 2020 is possible if these three things happen:

Cannabis in Canada could rebound

The cannabis market in Canada could be in store for a major course correction compared to a very lackluster 2019.

The legal cannabis industry in Canada is inefficient. Many people have turned back to the black market because it’s easier and often a lot less expensive than shopping at legitimate licensed businesses that Aurora supplies.

Logistics, distribution across individual provinces, and building up enough supply to serve the demand in Canada proved to be a huge hurdle for Aurora last year.

The company spent a significant amount of money building out its infrastructure, reworking its logistics and supply chain, and growing its supply.

2020 could be the year of exponential growth for cannabis companies in Canada, with Aurora leading the charge.

Still an industry leader

Aurora stumbled from a high of $15.07 on October 12, 2018 to an almost record low of just $2.48 at close on January 27, 2020. Despite this fall, ACB continues to be a cannabis industry leader.

The company is still the second largest company as far as sales and overall growing capacity are concerned in Canada.

As well, Aurora is currently responsible for the three best-selling cannabis products in several major Canadian markets. Sales figures in Europe for Aurora are also up considerably.

If the company can push forward with streamlined logistics and an ample enough supply to meet the demand, ACB should see a big bounce later in the year.

Too cheap for its own good

ACB could be primed for a big year because it is currently trading at such a low price.

It isn’t difficult to imagine that this company currently valued at about $2.5 billion could be worth $5 billion or more in the next year. If the company can even out some of the balance sheet and liquidity concerns that have made more risk-averse investors a little bit cautious, the stock could see a big jump in 2020.

Foolish takeaway

While 2019 was a terrible year for ACB, 2020 could be a turnaround point for the marijuana industry. If these three reasons mentioned above become true, Aurora’s stock could double in 2020.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »